In addition, knockdown of CLTC using siRNA restored tamoxifen sensitivity in OHTR cells, and an examination of public microarray datasets revealed that low levels of CLTC expression correlated with better rates of survival for breast cancer patients. The gene discussed is CLTC; the disease is breast cancer.